Taysha Gene Therapies: Funding, Investors & Team (Oct 2026)
Taysha Gene Therapies is dedicated to eliminating serious and life-threatening genetic diseases in the central nervous system. Our main goal is to develop treatments that can provide a cure, allowing us to quickly transition from laboratory research to patient treatment. By leveraging the expertise of our team in gene therapy and collaborating with the prestigious UT Southwestern Gene Therapy Program, we have created a robust pipeline of AAV gene therapy options that target rare and common diseases.
Taysha Gene Therapies has raised $710M across 7 funding rounds on record, the most recent an undisclosed round of $200M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Taysha Gene Therapies Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Taysha Gene Therapies Funding Rounds
Taysha Gene Therapies raised $95.0M in an undisclosed round announced in Aug 2020.
1 years later, a Post-IPO Debt of $100M was announced in Aug 2021.
1.2 years later, a Post-IPO Equity of $50.0M was announced in Oct 2022.
10 months later, an undisclosed round of $150M was announced in Aug 2023.
4 months later, an undisclosed round of $40.0M was announced in Dec 2023.
6 months later, an undisclosed round of $75.0M was announced in Jun 2024.
2 years later, an undisclosed round of $200M was announced in Jun 2026.
Taysha Gene Therapies Founders and Leadership Team
Contact details for the Taysha Gene Therapies team: 2 of 4 have an email address on file.
Start 14-day free trial →Taysha Gene Therapies Funding Compared to Other Biotechnology Startups
Taysha Gene Therapies' latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Taysha Gene Therapies in Biotechnology and Dallas
Companies Similar to Taysha Gene Therapies
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Taysha Gene Therapies Funding FAQs
What does Taysha Gene Therapies do?
Taysha Gene Therapies is dedicated to eliminating serious and life-threatening genetic diseases in the central nervous system. Our main goal is to develop treatments that can provide a cure, allowing us to quickly transition from laboratory research to patient treatment. By leveraging the expertise of our team in gene therapy and collaborating with the prestigious UT Southwestern Gene Therapy Program, we have created a robust pipeline of AAV gene therapy options that target rare and common diseases.
How much funding has Taysha Gene Therapies raised?
Taysha Gene Therapies has raised $710M across 7 rounds on record. The most recent is an undisclosed round of $200M announced in Jun 2026.
When did Taysha Gene Therapies last raise funding?
Taysha Gene Therapies' most recent funding round on record is an undisclosed round of $200M, announced in Jun 2026.
Who founded Taysha Gene Therapies?
FundedIQ lists Sean Nolan (Founder) at Taysha Gene Therapies.
Who is the CEO of Taysha Gene Therapies?
R.A. Session II is listed as CEO at Taysha Gene Therapies.
Where is Taysha Gene Therapies headquartered?
Taysha Gene Therapies is based in Dallas, Texas, United States.
How many employees does Taysha Gene Therapies have?
Taysha Gene Therapies is in the 101-250 employee band.
How does Taysha Gene Therapies' funding compare to other Biotechnology startups?
Taysha Gene Therapies' latest round of $200M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Taysha Gene Therapies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Taysha Gene Therapies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.